Aim & Scope
Open Access Government produces compelling and informative products for a wide audience. Our dedicated team have many years’ experience and are committed to delivering up-to-date analysis, news and exclusive features for a public and private sector readership. [1]
Continuations / Journal History
| ( 2014 - 2017 ) | Adjacent Government | ( 2017 - 9999 ) | Open Access Government |
2024 - VOLUME 43, ISSUE 1
How the dark genome enlightens the molecular mechanisms of diseases
Open Access Government , 2024 - VOLUME 43, ISSUE 1 , pp 20-21.
0
0
Algorithm “DPTM” for continuous authentication with behavioural biometrics
Open Access Government , 2024 - VOLUME 43, ISSUE 1 , pp 25-253.
0
0
Detoxification: The science behind social media claims of detox health benefits
Open Access Government , 2024 - VOLUME 43, ISSUE 1 , pp 32-33.
0
0
Promoting risky play: Insights from the Outside Play Lab
Open Access Government , 2024 - VOLUME 43, ISSUE 1 , pp 36-37.
0
0
The challenge of generating lasting mucosal anti-viral sterilising immunity
Open Access Government , 2024 - VOLUME 43, ISSUE 1 , pp 40-41.
0
0
National sepsis strategy to improve knowledge, prevention and treatment
B Bigham , R Brundin-Mather , A Carter , ... , J Leigh
Open Access Government , 2024 - VOLUME 43, ISSUE 1 , pp 46-47.
0
0
A comprehensive approach to integrated one health surveillance and response
A Basheer , W Jentner , K Kuhn , ... , D Ebert
Open Access Government , 2024 - VOLUME 43, ISSUE 1 , pp 50-51.
0
0
Getting leptospirosis onto the lists of neglected tropical diseases
J Vinetz , A Chetrick , K Steimel , ... , S Agampodi
Open Access Government , 2024 - VOLUME 43, ISSUE 1 , pp 52-54.
0
0
How the “tides” have turned in pharma manufacturing
Open Access Government , 2024 - VOLUME 43, ISSUE 1 , pp 64-65.
0
0